These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 19029299
1. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Alamuri P, Eaton KA, Himpsl SD, Smith SN, Mobley HL. Infect Immun; 2009 Feb; 77(2):632-41. PubMed ID: 19029299 [Abstract] [Full Text] [Related]
10. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Li X, Lockatell CV, Johnson DE, Lane MC, Warren JW, Mobley HL. Infect Immun; 2004 Jan; 72(1):66-75. PubMed ID: 14688082 [Abstract] [Full Text] [Related]
11. Vaccines for Proteus mirabilis in urinary tract infection. Li X, Mobley HL. Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833 [Abstract] [Full Text] [Related]
12. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Mobley HL, Belas R, Lockatell V, Chippendale G, Trifillis AL, Johnson DE, Warren JW. Infect Immun; 1996 Dec; 64(12):5332-40. PubMed ID: 8945585 [Abstract] [Full Text] [Related]
16. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Burall LS, Harro JM, Li X, Lockatell CV, Himpsl SD, Hebel JR, Johnson DE, Mobley HL. Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805 [Abstract] [Full Text] [Related]
17. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Massad G, Lockatell CV, Johnson DE, Mobley HL. Infect Immun; 1994 Feb; 62(2):536-42. PubMed ID: 7905463 [Abstract] [Full Text] [Related]
18. Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection. Johnson DE, Bahrani FK, Lockatell CV, Drachenberg CB, Hebel JR, Belas R, Warren JW, Mobley HL. Infect Immun; 1999 Dec; 67(12):6683-7. PubMed ID: 10569791 [Abstract] [Full Text] [Related]
19. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection. Zhao H, Thompson RB, Lockatell V, Johnson DE, Mobley HL. Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875 [Abstract] [Full Text] [Related]
20. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Mobley HL, Chippendale GR, Swihart KG, Welch RA. Infect Immun; 1991 Jun; 59(6):2036-42. PubMed ID: 2037363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]